Table 2. Secondary outcomes among children born post-term or at term.

		Post-term children	Term children	p-value
n		36	41
Glucose homeostasis	Acute insulin response (mU/l)	418 (339–516)	304 (235–392)	0.037
	Glucose effectiveness (10-2/min)	2.25 (1.52–3.33)	3.11 (2.01–4.83)	0.047
	Disposition index	3539 (2406–5205)	3576 (2271–5630)	0.95
	Fasting insulin (mU/l)	5.72 (4.38–7.49)	5.20 (3.76–7.19)	0.43
	Fasting glucose (mg/dl)	86.1 (82.9–89.2)	87.2 (83.4–91.0)	0.43
Hormone concentrations	Leptin (ng/ml)	6.96 (4.99–8.92)	4.49 (2.13–6.86)	0.008
	Adiponectin (μg/ml)	7.82 (4.64–9.20)	10.75 (9.32–12.17)	0.005
	IGF-I (ng/ml)	204 (168–240)	200 (157–243)	0.78
	IGFBP-1 (ng/ml)	10.6 (7.8–13.5)	17.6 (14.6–20.5)	0.002
	Androstenedione (nmol/l)	0.44 (0.33–0.54)	0.59 (0.48–0.70)	0.055
	DHEAS (nmol/l)	4.59 (2.53–6.66)	6.12 (3.59–8.64)	0.11
24-hour blood pressure monitoring	Mean arterial pressure (mmHg)	73.4 (70.0–76.8)	76.2 (72.0–80.5)	0.09
	Nocturnal systolic dipping (%)	9.7 (6.2–13.2)	13.5 (9.2–17.8)	0.027
	Nocturnal diastolic dipping (%)	15.6 (11.1–20.1)	19.4 (13.8–25.1)	0.079
Inflammatory markers	CRP (ng/ml)	457 (63–851)	490 (6–974)	0.86
	Uric acid (μmol/l)	229 (211–247)	201 (181–220)	0.033

Data are means and 95% confidence intervals adjusted for other confounding factors in the multivariate models.